Diagnostic Utility of SARS-CoV-2 Nucleocapsid Antigenemia: A Meta-analysis
Nucleocapsid antigenemia currently has limited utility due to limitations of existing studies and lack of Omicron-era data. Improved study designs targeting potential clinical uses in screening, surveillance, and complex clinical decision-making-especially in immunocompromised patients-are needed.
Authors
- Michael Goodman (ORCID: https://orcid.org/0000-0001-6956-6879)
- Hans Verkerke (ORCID: https://orcid.org/0000-0002-5152-0095)
- Sydney E Martin
- Wilbur Aaron Lam (ORCID: https://orcid.org/0000-0002-0325-7990)
- Eli Wilber (ORCID: https://orcid.org/0000-0001-8413-2681)
- Gregory L. Damhorst (ORCID: https://orcid.org/0000-0002-2237-1713)
Institutions
- Georgia Institute of Technology (US)
- Emory University (US)
- The Wallace H. Coulter Department of Biomedical Engineering (US)
- Aflac (United States) (US)
- Children's Healthcare of Atlanta (US)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2024-09-27
- DOI
- https://doi.org/10.1093/ofid/ofae561
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Norges Idrettshøgskole
- General Logistics Department, People's Liberation Army